By Heidi Chen 30 Nov 2017
Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D
60 Total results for product and free and sample content found
By Christina DeRuzza 24 Nov 2017
China’s 13th five-year plan 2016–20 will move the country into the center of the international stage of drug development, where they will be global innovators in the industry and more competitive than ever with foreign firms.
By Laura Runkel 19 Jun 2017
Biosimilars for autoimmune drugs, including humira, remicade, etanercept, rituximab and others, have been in clinical development for several years.
By Christine Blazynski 01 Jun 2017
The standard of care treatment for multiple sclerosis involves immunomodulatory therapy to relieve and/or modify symptoms; the vast majority of these are large biologic molecules and are administered via injection.
Topic Multiple Sclerosis
By Doro Shin 31 May 2017
One Size No Longer Fits All comes to you from In Vivo, part of the Informa Pharma Intelligence suite of tools. Leveraging a unique array of news, data, analysis, and consulting products and services.
Topic Personalized Medicine
By Christine Blazynski PhD 30 May 2017
Company pipeline depictions are snapshots that illustrate, at that point in time, where a therapeutic candidate sits in terms of development stage for a specific therapy area or disease.
By Ethan Hebert 19 Apr 2017
Currently there are no approved pharmacological treatments for non-alcoholic fatty liver disease (NAFLD), including the subtype non-alcoholic steatohepatitis (NASH).
Topic Clinical trials
By Robin Custeau 01 Apr 2017
Given the current limited options and future demand for renal anemia treatment, pharmaceutical companies will have an opportunity to capitalize on this market.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: